Health TrialsbyHealthPanel

Percutaneous Achilles Tendon Tenotomy vs Tendo-Achilles Lengthening (TAL) in Neglected Clubfoot Children.

ConditionClubfoot
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age2-5
SponsorMuhammad Aamir Latif

About this trial

Achilles tendon tenotomy is the established worldwide gold standard for correcting idiopathic clubfoot. However, in neglected cases, surgical interventions such as percutaneous Achilles tendon tenotomy (PAT) and open tendo-Achilles lengthening (TAL) are common techniques for correcting this deformity. This study aimed at determining the functional outcomes of Percutaneous Achilles Tendon Tenotomy (PAT) vs tendo-Achilles Lengthening (TAL) in the neglected clubfoot children of age 2-5 years.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Any gender

Aged 2-5 years

diagnosed with clubfoot

Pirani score 3-6

Disqualifiers

Patients with other neuromuscular, chromosomal abnormalities

myelomeningocele

Dystrophic dysplasia

Moebius syndrome

Trial population

Newly diagnosed patients of clubfoot between 2 and 5 years of age having Pirani score 3-6 within the study period will be recruited.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Tenotomy of Achilles Tendon

    Procedure/Surgery

    Patients will be started on serial casting and manipulation according to ponseti method. After successful correction of cavus, varus, and adductus, patients will be treated using the tenotomy of Achilles tendon technique.

  • Tendo-Achilles Lengthening

    Procedure/Surgery

    Patients will be started on serial casting and manipulation according to ponseti method. After successful correction of cavus, varus, and adductus, patients will be treated using the Tendo-Achilles Lengthening technique.

Treatment groups

44 Participants
are divided into 2 treatment groups
Group A: Percutaneous Achilles Tendon Tenotomy-Group1 intervention
Group B: Tendo-Achilles Lengthening-Group1 intervention

Trial outcomes

Primary outcomes

1

Improvement in ankle dorsiflexion

Frequency of patients with improvement in ankle dorsiflexion will be noted.

Time frame
6 months

Secondary outcomes

1

Bleeding

Frequencies of bleeding as none, mild moderate, and severe will be noted.

Time frame
1 hour
2

Infection

Frequency of patients who had an infected wound will be noted.

Time frame
6 months
3

Incomplete tenotomy

Frequency of patients who will have incomplete release or residual deformity assessed after 6 months.

Time frame
6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Muhammad Aamir Latif

Lead sponsor

RESnTEC, Institute of Research

Sponsor institution

Source ClinicalTrials.gov
Apply now